1. oxbum49791
2. latinoboyz4874
3. rpereira07
4. MamisTrist
5. franklola4509
1.813kimd 02/18/2018
Novartis AG is preparing to sell its U.S. generic pill business,
2.WalkingDeader 01/22/2018
Novartis completes tender offer for Advanced Accelerator Applications S.A. and announces commencement of subsequent offering period
3.WalkingDeader 01/26/2018
UPGRADES SOON - Reports of EPS beat ranging from $0.02 to $0.04. Beats on revenues.
4.oxbum49791 01/18/2018
Superiority of Cosentyx® versus Stelara®* in achieving skin clearance for psoriasis patients
5.rpereira07 01/25/2018
Wow!! ... More Awesome news for $NVS
6.MamisTrist 01/22/2018
Good stuff!
7.boxerrunner27 03/26/2018
Phase III data in The Lancet show Novartis siponimod significantly improves outcomes in patients with secondary progressive MS
8.MamisTrist 02/14/2018
Novartis forms alliance to develop medicines for treating infectious diarrheal disease
9.latinoboyz4874 05/31/2018
FDA expedites review of Novartis drug Promacta® for first-line severe aplastic anemia (SAA)
10.813kimd 01/29/2018
FDA Approval for Lutathera
NEW since the last time you visited this board.
Currently a TOP 10 POST for this board.
Currently a TOP 5 RESEARCHER for this board.
Specific post has replies to it.
A Researcher you are currently FOLLOWING
Other Researchers rate this post HIGH
Other Researchers rate this post LOW